Aditya Birla Sun Life Pharma And Healthcare Fund-Regular-Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-07-2019
AUM:
₹ 1,010.54 Cr
Expense Ratio
2.28%
Benchmark
BSE Healthcare TRI
ISIN
INF209KB1N91
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Dhaval Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Aditya Birla Sun Life Pharma And Healthcare Fund-Regular-Growth | 13.72 | 20.79 | 13.63 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
36.06
Last change
0.45 (1.2479%)
Fund Size (AUM)
₹ 1,010.54 Cr
Performance
19.87% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Fund Manager
Mr. Dhaval Shah
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 12.42 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.31 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.75 |
| JB Chemicals & Pharmaceuticals Limited | 4.73 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.37 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 3.99 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.89 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.73 |
| ABBOTT INDIA LIMITED EQ | 3.65 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.31 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 95.16 |
| Financial Services | 1.01 |
| Chemicals | 0.65 |